22 results
8-K
EX-10.1
LFCR
Lifecore Biomedical Inc
5 Jan 24
Entry into a Material Definitive Agreement
4:09pm
– Lifecore Biomedical, Inc. – Limited Waiver and First Amendment – Page 3 of such earlier date; provided, in each case, such materiality qualifier … shall not apply to any representations and warranties to the extent already qualified or modified by materiality or similar concept in the text thereof
8-K
LFCR
Lifecore Biomedical Inc
31 Oct 23
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
6:17am
assessed the materiality of these errors in accordance with the U.S. Securities and Exchange Commission Staff Accounting Bulletin No. 99 (“SAB … ”), Materiality and SAB No. 108, Quantifying Financial Statement Misstatements, and has concluded that the prior financial statements referenced above should
8-K
EX-10.1
LFCR
Lifecore Biomedical Inc
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
; provided, in each case, such materiality qualifier shall not apply to any representations and warranties to the extent already qualified or modified … by materiality or similar concept in the text thereof; and
(iii)as of such Credit Date, no event shall have occurred and be continuing or would result
8-K
EX-10.1
LFCR
Lifecore Biomedical Inc
25 Nov 22
Entry into a Material Definitive Agreement
4:51pm
of materiality, reasonableness, good faith, and fair dealing with respect to those jurisdictions that recognize such concepts). (i) Such Purchaser
8-K
84zg5vda00hloeb
13 Sep 22
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
9:45pm
8-K
EX-2.1
zy58sho43y
17 Dec 21
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-10.1
dicjc
5 Jan 21
Landec Corporation Announces Comprehensive Refinancing of Credit Facilities
3:00pm
8-K
EX-10.1
eqaol410x0yvt
17 Jul 20
Landec Corporation Amends Credit Agreement
12:00am
8-K
EX-10.1
u5wx wud3mfk6a
25 Mar 20
Landec Corporation Amends Credit Agreement, Appoints Brian McLaughlin Chief Financial Officer
5:22pm
8-K
EX-10.1
1j4h2q8pe a4hbs
30 Oct 19
Landec Corporation Amends Its Credit Agreement
2:04pm
8-K
EX-10.1
59p7rrb3bcusj xg8
6 Dec 18
Entry into a Material Definitive Agreement
3:20pm
8-K
EX-10.1
dbr j0cmspwd
27 Apr 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
b6ggvu6rba
18 Feb 11
Landec Subsidiary, Apio Inc., Announces Equity Investment
12:00am
8-K
EX-10.1
5ktmxkejo0
5 May 10
Landec Corporation Acquires Lifecore Biomedical
12:00am
CORRESP
tbrs7
9 Apr 07
Correspondence with SEC
12:00am
8-K
EX-10.70
bn46di6c4b473gs7ncrt
6 Dec 06
Landec Enters into Agreements with Monsanto Potentially Valued at Over $70 Million
12:00am
8-K
EX-2.1
9n4ca2
7 Nov 02
Acquisition or disposition of assets
12:00am
8-K
EX-2.1
ivhe6ritxxsd6xl0
17 Dec 99
Current report
12:00am